In line with having AD pathology, AD+ classifications were more likely to have MCI or ADD, progression to MCI/ADD in the future, be older, and have ≥1 APOE ε4 alleles, compared to AD− and Intermediates (Table 2). This evidence concerns the gene APOE and Alzheimer disease.